ProQR participates in the LifeSci 2nd Annual Genetic

LEIDEN, The Netherlands & CAMBRIDGE, Massachusetts, June 28, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics NV (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives by creating transformative RNA therapies , today announced that the company’s management will participate in the Life Sci 2nd Annual Genetic Medicines Symposium on June 29, 2022 as part of …

ProQR participates in the LifeSci 2nd Annual Genetic Read More »